Stockscreener 앱 받기
0.4211
5.18%
-0.023
시간 외 거래:
.42
-0.0011
-0.26%
전일 마감가:
$0.4441
열려 있는:
$0.4691
하루 거래량:
33,438
Relative Volume:
0.37
시가총액:
$16.87M
수익:
$3.81M
순이익/손실:
$-7.29M
주가수익비율:
-1.9687
EPS:
-0.2139
순현금흐름:
$-5.72M
1주 성능:
-7.25%
1개월 성능:
-13.00%
6개월 성능:
-52.73%
1년 성능:
-59.90%
1일 변동 폭
$0.4173
$0.4691
1주일 범위
$0.4173
$0.489
52주 변동 폭
$0.3401
$1.60
Dyadic International Inc De Stock (DYAI) Company Profile
명칭
Dyadic International Inc De
전화
561-743-8333
주소
1044 NORTH U.S. HIGHWAY ONE, JUPITER
Compare DYAI vs VRTX, MRNA, REGN, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DYAI
Dyadic International Inc De
|
0.4211 | 16.87M | 3.81M | -7.29M | -5.72M | -0.2139 |
VRTX
Vertex Pharmaceuticals Inc
|
507.00 | 128.50B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
213.74 | 85.33B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
762.81 | 78.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
812.30 | 51.08B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
193.95 | 41.57B | 742.00K | -1.37B | -1.07B | -7.0731 |
Dyadic International Inc De Stock (DYAI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-23 | 재개 | H.C. Wainwright | Buy |
| 2025-09-08 | 개시 | Craig Hallum | Buy |
| 2022-07-18 | 다운그레이드 | Dawson James | Buy → Neutral |
| 2021-12-17 | 개시 | H.C. Wainwright | Buy |
Dyadic International Inc De 주식(DYAI)의 최신 뉴스
Dyadic International stock faces two Nasdaq compliance tests - AD HOC NEWS
Dyadic International stock faces two Nasdaq compliance tests - AD HOC NEWS
Dyadic International (Nasdaq:DYAI)Stock Analysis - Simply Wall Street
Dyadic International Faces Nasdaq Listing Compliance Challenges - The Globe and Mail
Form 8K Dyadic International Inc For: 25 September By Investing.com - Investing.com Nigeria
Dyadic International Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Dyadic gets Nasdaq notices over $1, $35M rules - Stock Titan
Dyadic International stock rises 2.5 percent as warrants add risk - AD HOC NEWS
Dyadic International stock trades without a fresh market catalyst - AD HOC NEWS
Dyadic International stock edges higher as S-1 registration becomes effective - AD HOC NEWS
DYADIC INTERNATIONAL INC SEC Filing (Sep 21, 2026) - Stock Titan
Emerging Growth Patterns Driving Rapid Expansion in the Protein Hydrolysis Enzymes Market - openPR.com
iAccess Alpha Virtual Best Ideas Fall Investment Conference, September 15-16, 2026 - Finviz
Dyadic International (Nasdaq: DYAI) Advances Protein Manufacturing Platforms with Global Health Research Support - usatoday.com
Imperium AI Announces Board Discussion Regarding Dyadic Biotechnology Developments - usatoday.com
Dyadic International (Nasdaq: DYAI) Advances Next-Generation Biomanufacturing With Global Health Support to Help Turn AI-Designed DNA Into Life-Saving Products - StreetInsider
Dyadic International (DYAI) Q2 2026 Earnings Call Transcript - AOL.ca
Amylase Enzyme Cleaner Market Growth to 2035 Driven by Membrane Filtration DemandNews and Statistics - IndexBox
Llamada de resultados del T2 de 2026 de Dyadic International (DYAI): progreso comercial y riesgo de liquidez - TradingKey
Dyadic International Announces New Equity Financing Agreements - TipRanks
Dyadic International (DYAI) Ergebniskonferenz Q2 2026: Kommerzielle Fortschritte und Liquiditätsrisiko - TradingKey
Dyadic International (NASDAQ: DYAI) prices $2.9M stock sale and warrant placement - Stock Titan
Dyadic International Earnings Call: Promise Amid Cash Strain - TipRanks
Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement - GlobeNewswire
Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement - GlobeNewswire
Dyadic International, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Dyadic raises $2.9 million in registered direct offering - Investing.com
Dyadic International Warns of Going-Concern Risk as Dilution, Nasdaq Uncertainty and Noteholder Dependence Threaten Shareholder Value - TipRanks
Dyadic International Q2 Results: EPS Misses Estimate, Sales Down 0.6% YoY - scanx.trade
Dyadic Announces Second Quarter 2026 Financial Results - GlobeNewswire
Dyadic reports Q2 loss amid commercialization efforts - Investing.com
Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas - Yahoo Finance
Dyadic International Inc (DYAI) (Q2 2026) Earnings Call Highlights: Revenue Surges 52% as ... - Yahoo Finance
Earnings To Watch: Dyadic International Inc (DYAI) Q2 2026 -- GF Value Sees 40% Downside - Yahoo Finance
Cellulase Silage Additives Market Growth to 2035 Driven by Asia-Pacific Livestock ExpansionNews and Statistics - IndexBox
Segmentation, Major Trends, and Competitive Overview of the Specialty Enzymes Market - openPR.com
Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement - GlobeNewswire
Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement - GlobeNewswire
Dyadic signs license deal for precision-fermented dairy proteins - Investing.com
Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026 - GlobeNewswire
Dyadic Delivers Two Bundibugyo Ebola Antigens for Preclinical Evaluation - Stock Titan
Form 4 Dyadic International Inc For: 25 July By Investing.com - Investing.com South Africa
Form 4 Dyadic International Inc For: 25 July By Investing.com - Investing.com Canada
Francisco trust disposes of $124,957 in Dyadic International stock By Investing.com - Investing.com Canada
Dyadic Regains Nasdaq Compliance, Secures Continued Listing - TipRanks
Dyadic regains compliance with Nasdaq listing requirements By Investing.com - Investing.com Canada
Dyadic International, Inc. (DYAI) stock price, news, quote and history - Yahoo Finance Singapore
Dyadic Announces Continued Listing on the Nasdaq Capital Market - GlobeNewswire
Dyadic Announces Continued Listing on the Nasdaq Capital Market - GlobeNewswire
Dyadic regains compliance with Nasdaq listing requirements - Investing.com
Dyadic International Inc De (DYAI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Dyadic International Inc De 주식 (DYAI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Francisco Trust under agreemen | 10% Owner |
Jul 24 '26 |
Sale |
1.21 |
2,616 |
3,173 |
3,280,272 |
| Francisco Trust under agreemen | 10% Owner |
Jul 22 '26 |
Sale |
1.33 |
38,016 |
50,481 |
3,337,648 |
| Francisco Trust under agreemen | Greater than 10% holder |
Jul 21 '26 |
Proposed Sale |
1.48 |
364,387 |
539,296 |
0 |
1.46%
자본화:
|
볼륨(24시간):